治疗组应用低分子肝素联合尿激酶，对照组仅用扩容治疗。
In the treating group, LMWH combined with urokinase were given, while in the control group merely hypervolemic treatment was given.
目的：探讨血液粘度与有效血容量之间的关系，为扩容治疗提供理论依据。
Objective:To explore the relationship of blood viscosity with effective blood volume in order to provide the scientific theoretic basis for treatment with dilation of blood volume.
本发明的药物组合物用于治疗和预防血容量不足，能够在大剂量输液进行扩容治疗时避免高氯代谢性酸中毒的风险。
The medicine composition is used for preventing and treating hypovolemia and may be used in great dosage infusion without risk of hyperchloremic metabolic acidosis.
结果OHSS经过严密监护输白蛋白或血浆，扩容及放腹水等对症治疗后可治愈。
Results: OHSS could be controlled by intensive care, supplementation of albumin or plasma , volume expansion, and paracentesis.
低分子肝素抗凝、低分子右旋糖苷扩容为其主要的治疗手段。
The main treatment was low molecular weight heparin anticoagulation and low molecular weight dextran expansion.
采用降颅压、扩容、抗凝及溶栓等治疗，10例痊愈，4例好转，1例死亡，1例自动出院。
After treatment by decreasing intracranial pressure, anticoagulation or thrombolysis, 10 cases recovered, 4 cases were better, 1 case died, 1 case gave up.
采用降颅压、扩容、抗凝及溶栓等治疗，10例痊愈，4例好转，1例死亡，1例自动出院。
After treatment by decreasing intracranial pressure, anticoagulation or thrombolysis, 10 cases recovered, 4 cases were better, 1 case died, 1 case gave up.
应用推荐